Table 1 Baseline characteristic of patient population
Control group (N = 132) | IABP group (N = 125) | P value | |
|---|---|---|---|
Age(y) | 62.4 ± 8.4 | 62.6 ± 8.5 | 0.81 |
Male (%) | 113 (85.6%) | 96 (76.8%) | 0.07 |
BMI | 25.3 ± 3.8 | 25.3 ± 2.9 | 0.86 |
Smoker (%) | 72 (54.5%) | 65 (52.0%) | 0.68 |
Hypertention (%) | 73 (55.3%) | 69 (55.2%) | 0.98 |
Diabetes (%) | 35 (26.5%) | 47 (37.9%) | 0.05 |
MI (%) | 12 (9.1%) | 35 (28.0%) | < 0.001 |
COPD (%) | 2 (1.5%) | 5 (4.0%) | 0.22 |
PCI (%) | 8 (9.6%) | 12 (6.1%) | 0.30 |
Cholesterol (mmol/l) | 5.2 ± 9.3 | 4.1 ± 1.7 | 0.14 |
Creatinine (umol/l) | 75.0 ± 19.0 | 79.9 ± 23.1 | 0.07 |
EF(%) | 61.9 ± 7.4 | 52.5 ± 11.3 | < 0.001 |
LVDD (mm) | 51.2 ± 6.8 | 47.8 ± 4.4 | < 0.001 |
NYHA class | < 0.001 | ||
II | 112 (87.5%) | 77 (62.6%) | |
III | 15 (11.7%) | 46 (37.4%) | |
IV | 1 (0.78%) | 0 (0%) | |
Unstable angina | 97 (73.5%) | 91 (72.8%) | 0.90 |
Carotid artery stenosis, n (%) | 28 (21.5%) | 16 (12.9%) | 0.07 |
Stoke | 1 (0.8%) | 2 (1.6%) | 0.53 |
Grafts, n | 0.630 | ||
2 | 15 (11.4%) | 16 (12.8%) | |
3 | 96 (73.2%) | 85 (68.0%) | |
4 | 20 (15.2%) | 24 (19.2%) | |
LIMA | 86 (65.6%) | 65 (52.0%) | 0.026 |